Charting a pathway to follow-on biologics

被引：0
|
作者：
Greb, Erik
机构：
来源：
Pharmaceutical Technology | 2009年 / 33卷 / 06期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：36 / 42
相关论文
共 50 条
  • [21] A GUIDE TO FOLLOW-ON BIOLOGICS AND BIOSIMILARS WITH A FOCUS ON INSULIN
    Dolinar, Richard
    Lavernia, Frank
    Edelman, Steven
    ENDOCRINE PRACTICE, 2018, 24 (02) : 195 - 204
  • [22] Demystifying the Differences: Follow-on Biologics, Biosimilars, and Generics
    Wright, Eugene E., Jr.
    Blevins, Thomas C.
    Reed, Beverly
    Pollom, Roy Daniel
    JOURNAL OF FAMILY PRACTICE, 2017, 66 (04): : S22 - S27
  • [23] Current Regulatory and Legal Considerations for Follow-On Biologics
    Kingham, R. F.
    Lietzan, E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (05) : 633 - 635
  • [24] Active Surveillance of Follow-on Biologics: A Prescription for Uptake
    Sarpatwari, Ameet
    Gagne, Joshua J.
    Levidow, Nicole L.
    Kesselheim, Aaron S.
    DRUG SAFETY, 2017, 40 (02) : 105 - 108
  • [25] The challenge of follow-on biologics for treatment of multiple sclerosis
    Reingold, S. C.
    Steiner, J. P.
    Polman, C. H.
    Cohen, J. A.
    Freedman, M. S.
    Kappos, L.
    Thompson, A. J.
    Wolinsky, J. S.
    NEUROLOGY, 2009, 73 (07) : 552 - 559
  • [26] THE CHALLENGE OF FOLLOW-ON BIOLOGICS FOR TREATMENT OF MULTIPLE SCLEROSIS
    Rivera, Victor M.
    NEUROLOGY, 2010, 74 (10) : 864 - 864
  • [27] Manufacturing issues shape follow-on biologics debate
    Wechsler, Jill
    Pharmaceutical Technology, 2007, 31 (06) : 30 - 40
  • [28] Active Surveillance of Follow-on Biologics: A Prescription for Uptake
    Ameet Sarpatwari
    Joshua J. Gagne
    Nicole L. Levidow
    Aaron S. Kesselheim
    Drug Safety, 2017, 40 : 105 - 108
  • [29] Japanese Biotech Patenting Strategies in the Era of Follow-On Biologics
    Tessensohn, John A.
    Yamamoto, Shusaku
    BIOTECHNOLOGY LAW REPORT, 2009, 28 (04) : 483 - 496
  • [30] What follow-on biologics mean for the future of the biotechnology industry
    Hussain, Ajaz S.
    Woollett, Gillian R.
    BIOPHARM INTERNATIONAL, 2007, 20 (11) : 32 - +
12345